Showing results (11-20 of 160) with videos related to

Sort By:
Pageof 16
Vaccine|August 20, 2021
Therapeutic activity of a Salmonella-vectored Schistosoma mansoni vaccine in a mouse model of chronic infectionAdam S Hassan, Dilhan J Perera, Brian J Ward, et al.
Vaccine|June 23, 2018
A novel serological assay for influenza based on DiD fluorescence dequenching that is free from observer bias and potentially automatable - A proof of concept studyAlexander I Makarkov, Aakash R Patel, Valentine Bainov, et al.
Vaccine|November 21, 2013
Immunologic characterization of a novel inactivated nasal mumps virus vaccine adjuvanted with ProtollinKatie R Young, Sazini Nzula, David S Burt, et al.
Diagnostic Microbiology and Infectious Disease|January 28, 2014
Seroprevalence of parasitic zoonoses and their relationship with social factors among the Canadian Inuit in Arctic regionsStephanie Goyette, Zhirong Cao, Michael Libman, et al.
Vaccine|February 14, 2021
Phase III: Randomized observer-blind trial to evaluate lot-to-lot consistency of a new plant-derived quadrivalent virus like particle influenza vaccine in adults 18-49 years of ageBrian J Ward, Annie Séguin, Julie Couillard, et al.
Frontiers in Immunology|June 20, 2018
Neonatal Immunity, Respiratory Virus Infections, and the Development of AsthmaKatherine H Restori, Bharat T Srinivasa, Brian J Ward, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|August 4, 2015
A family cluster of Chagas disease detected through selective screening of blood donors: A case report and brief reviewGuillaume Mongeau-Martin, Momar Ndao, Michael Libman, et al.
Human Immunology|July 25, 2003
Novel TAP1 polymorphisms in indigenous Zimbabweans: their potential implications on TAP function and in human diseasesJulie Lajoie, Lynn S Zijenah, Marie Claude Faucher, et al.
Vaccine|March 22, 2007
C57Bl/6 mice are protected from respiratory syncytial virus (RSV) challenge and IL-5 associated pulmonary eosinophilic infiltrates following intranasal immunization with Protollin-eRSV vaccineSonya L Cyr, Taff Jones, Ioana Stoica-Popescu, et al.
Microorganisms|February 27, 2026
Current Applications and Immunological Considerations of Salmonella enterica Serovar Typhimurium as a Vaccine VectorAdam S Hassan, Kaitlin Winter, Charles M Dozois, et al.
Pageof 16